In addition, an abrogation of IGF2R could represent a selective advantage at the cirrhosis stage by impairing antiproliferative and pro-apoptotic signals induced by TGF-β, which is overexpressed in cirrhosis. The gene discussed is TGFB1; the disease is Cirrhosis.